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Abstract 
The influence of haemoglobin genotype on the response to iron supplementation was studied in a ran- 
domized, double blind, placebo-controlled trial involving 497 multigravid pregnant women from a rural 
area of The Gambia. Women were randomly allocated to receive either oral iron (60mg elemental iron per 
day) or placebo. At 36 weeks of pregnancy, women who had received oral iron during pregnancy had higher 
mean haemoglobin, packed cell volume, plasma iron and ferritin levels than did women who received 
placebo. Iron sup lementation 
creases in the pat IR 
of pre 
ed cell volume (P E 
nant women with the AA haemoglobin genotype also resulted in in- 
V) and haemoglobin level measured after delivery, and in the birth 
weight of the infant. However, in AS women PCV and haemoglobin level at delivery were lower in the sup- 
plemented group and supplementation was also associated with reduced birth weights. In malaria endemic 
areas, pregnant women with the haemoglobin genotype AS may not benefit from iron supplementation dur- 
ing pregnancy. 
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Introduction 
Anaemia is a common feature of pregnancy through- 
out the world, but it is especially important in developing 
countries where it may pose a threat to the life of both 
the mother and her baby (FLEMING? 1989). In most de- 
veloping countries, iron deficiency is the main cause of 
anaemia in pregnancy and therefore iron supplementa- 
tion is routinely recommended. However, in endemic 
areas, malaria may be an equally important cause of anae- 
mia, especially in primigravidae (BRABIN, 1983). Two 
studies have shown that parenteral iron administration 
during pregnancy increased susceptibility to malaria 
(BYLES & D’SA, 1970; OPPENHEIMER et al., 1986). We 
therefore carried out a controlled trial of iron supplemen- 
tation in pregnant women resident in a rural area of The 
Gambia where malaria is common. The effects of iron on 
both haematological measurements and on the pre- 
valence of malaria were followed carefully. Because rural 
Gambian women may have difficulties in reaching an 
antenatal clinic, iron supplementation was given by tradi- 
tional birth attendants (TBAs) resident in the villages of 
the pregnant women. The overall results of this trial, 
which have been presented elsewhere, were clear-cut 
(MENENDEZ et al., 1994). Iron supplementation in- 
creased the mean haemoglobin level and packed cell vol- 
ume (XV) of pregnant women overall and did not lead 
to any significant increase in the prevalence of malaria. 
However, during the analysis of these results, it was 
noted that the response to iron of pregnant women with 
the haemoglobin genotype AS appeared to be different 
from that of women with the haemoglobin genotype AA. 
We now present the results of a detailed analysis demon- 
strating that iron supplementation of pregnant Gambian 
women with the haemoglobin genotype AS was of no 
value and may even have been harmful. 
Subjects and Methods 
Study area and population 
The study was carried out in 15 villages near the town 
of Farafenni, North Bank Division, The Gambia. The 
demographic and geographical characteristics of the area 
have been described previously (GREENWOOD et al., 
1987). Its population is about 10 500, of whom approxi- 
mately 2500 are women between the ages of 15 and 45 
years. The area is one of seasonal malaria with high levels 
of transmission occurring during the 4-5 months of the 
rainy season. 
Address for correspondence: Dr. C. Menendez, Unidad de Epi- 
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Study design 
As described previously (MENENDEZ et al., 1994), 
multigravid pregnant women living in study villages 
were allocated at random to receive daily a single tablet 
of oral ferrous sulphate (60 mg elemental iron) or a single 
tablet of placebo from the time that pregnancy was recog- 
nized until delivery. In addition, each woman received a 
5 mg tablet of folic acid weekly; antimalarial drugs were 
not given. Primigravidae and second gravidae who were 
participating in a trial of antimalarial chemoprophylaxis 
were not included in the study. Tablets were issued 
weekly by TBAs living in the study villages. Tablets not 
used during the previous week were collected by the TBA 
and counted so as to provide a measure of compliance of 
drug consumption. Iron and placebo were coloured differ- 
ently to facilitate correct administration. However, all 
clinical and laboratory measurements were made by inves- 
tigators who did not know the treatment code. 
Each woman was visited by a physician (C.M.) on 3 
occasions. The first visit was made soon after a woman 
had reported to a TBA or Medical Research Council 
(MRC) field worker that she was pregnant, the second 4-- 
6 weeks before delivery, and the final visit within a week 
of delivery. At the first 2 visits gestational age was as- 
sessed by palpation of the fundal height and weight, 
height and skin fold thickness were recorded. At each 
visit approximately 1 mL of blood was collected bv 
finger-prick into a heparinized microtainer (Beckton 
Dickinson, Rutherford. New Tersev. USA) and thick 
and thin blood films ‘were p;epareh. After delivery, 
TBAs, who had been trained previously in the technique 
(MENENDEZ et al., 1993), collected 2 placental biopsy 
specimens and made 2 thick blood films from blood ob- 
tained from a cut surface of the placenta. The birth 
weight of each newborn infant was recorded by a field 
worker who did not know the treatment code, as soon as 
possible after birth. In the case of babies who were not 
seen during the first 24 h after delivery, an estimated 
birth weight was calculated using information obtained 
on weight-for-age during the first week of life in infants 
born to 963 Gambian miltigravidae. A maximum fall in 
birth weight of 2.5% was observed in these babies on the 
second day after birth. 
Laboratory methods 
The PCV and haemoglobin level (Hb) were measured 
by standard methods. The presence of abnormal haemo- 
globins was assessed following electrophoresis of a red 
blood cell haemolysate on cellulose acetate strips. Thick 
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blood films were stained with Giemsa’s stain and exam- 
ined for malaria parasites. At least 100 high power fields 
were examined before a film was reported to be negative. 
Plasma iron and iron binding capacity (UIBC) were 
measured by a calorimetric method (HARRISON et al., 
1987) using reagents obtained from the Sigma Chemical 
Company (Poole, Dorset, UK). Total iron-binding ca- 
pacity (TIBC) was obtained by adding together the 
values for plasma iron and UIBC. Transferrin saturation 
was calculated by dividing the plasma iron value by the 
TIBC and multiplying by 100. Plasma ferritin was 
measured by an enzyme-linked immunosorbent assay 
(SMITH et al., 1989) using a rabbit anti-ferritin antiserum 
obtained from Dako (UK). 
Placental biopsies were fured in 10% formol-saline or 
buffered formal-saline, and paraffin blocks were pre- 
pared in The Gambia within a few weeks of collection. 
Sections were cut subsequently in London and stained 
according to conventional histological techniques. 
Placentas were grouped into 4 categories dependent upon 
the presence or absence of parasites and pigment and the 
presence of active current and/or previous infecion dur- 
ing the pregnancy was determined (MENENDEZ et al., 
1994). 
Statistical methods 
Analysis of variance was used to compare charac- 
teristics at enrolment. Interaction terms were included in 
an analysis of covariance in order to test whether the ef- 
fects of supplementation varied between genotypes. In 
analyses of haematological measurements, the value ob- 
tained at enrolment was treated as a covariate. In the ana- 
lysis of birth weight, maternal height was treated as a co- 
variate. Categorical variables were compared using 
logistic regression. 
Results 
Seven hundred and fifty-seven multigravidae who 
were potentially eligible for the study were identified; 
207 were subsequently excluded because they were more 
than 34 weeks pregnant when first seen, delivered before 
a second antenatal visit was made,. had an abortion, 
moved away, died, or declined to lam the study. Thus 
550 women were enrolled, with a mean gestational age of 
23.8 weeks (standard deviation 5.2). At that time, 30 
women (5.4%) were found to have a PCV less than 25%, 
treated and withdrawn from the study; 520 women com- 
pleted the study and haemoglobin electrophoresis was 
performed for 500 of them; 98 (19.6%) had the haemo- 
globin genotype AS, (0.6%) had the genotype AC, and 
399 (79.8%) had the genotype AA. Women with haemo- 
globin AS or AA are the subjects of the remainder of this 
report. Baseline characteristics and compliance of the 4 
groups of women are shown in Table 1. The numbers of 
tablets consumed were very similar in all 4 groups. The 
baseline characteristics of the women who did not com- 
plete follow-up were also similar in all 4 groups (data not 
shown). Further details of compliance and follow-up 
have been given by MENENDEZ et aE. (1994). 
Haematological effects of iron supplementation 
Haematological findings at the end of pregnancy are 
shown in Table 2. As described by MENENDEZ ef ~2. 
(1994), iron supplementation was associated with signifi- 
cant increases in all haematological measurements and in 
plasma iron, plasma ferritin and transfer& saturation. 
The analysis of covariance (treating the initial measure- 
ments as covariates) also indicated that the AS genotype 
had significantly lower PCV and Hb, and higher levels of 
plasma iron, than AA women. None of the interaction 
terms was statistically significant so we cannot conclude 
Table 1. Characteristics of pregnant women on enrohnent into the study and number of tablets taken 
AA 
aemoglobin genotype 
AS 
reatment erouo 
Characteristics Irona Placeboa - 1 Irona Placeboa 
Age (years) 29.05k6.4 (200) 29.54k6.1 (198) 29.5Ok6.4 (46) 29.65k6.3 (52) 
Parity 4.18+2.1 (201) 4.0922.0 (198) 4.32k2.2 (46) 4.42f2.3 (52) 
Height (cm) 161.52f6.0 (199) 160.28k6.3 (196) 161.53f5.3 (46) 161.66f5.8 (50) 
Weight (kg) 55.09f7.1 (201) 54.26f7.2 (198) 55.3828.6 (46) 55.04k7.6 (52) 
Body fat (%) 28.52k4.5 (200) 28.3lk4.6 (198) 28.26k4.0 (46) 28.5Ok5.0 (52) 
No. of tablets taken 85.3Ok30.3 (201) 87.12f32.0 (198) 93.5lk24.6 (46) 84.7Ok25.9 (52) 
aMeans+standard eviations (numbers of women studied are given in parentheses). 
Table 2. Effect of iron supplementation on haematological and biochemical iron values adjusted for baseline values 
at 36 weeks of ~remancv 
m I. I oral iron 
Packed cell 
Genotype Treatment volume (%)a 
HaTrgl9bin Iron 1. binding I Ferrit@ Transferrin 
/ ‘dLY (unlol/L) capacity (umol/L~ WJ-) saturation (%)a 
E 
Iron 31.7f3.5 (197) 10.5fl.5 (163) 12.18 [1.75] (169) 89.7k3.40 (156) 99.48 [1.82] (193) 18.Okl.23 (156) 
Placebo 29.3k3.9 (193) 9.6kl.6 (156) 9.97 [1.75] (167) 93.4k3.09 (162) 60.34 [1.97] (189) 14.4kl.25 (161) 
AS Iron 29.9k4.4 (41) 9.8kl.6 (36) 14.88 [1.70] (38) 81.6k4.80 (38) 121.51 [1.77] (44) 22.422.50 (38) 
AS Placebo 28.7k3.5 (50) 9.4kl.6 (40) 11.02 [1.70] (49) 96.5k6.35 (46) 73.70 [1.86] (51) 13.9kl.82 (46) 
Analyses of variance‘ 
Main effects 
Genotype 
F 
P 
7.23 4.18 4.27 0.16 
CO.01 CO.05 <0.05 >0.5 
2.12 
>O.l 
0.75 
r0.4 
Iron 
; 
43.37 31.97 11.60 4.12 48.40 14.01 
<O.OOl CO.001 <O.OOl <0.05 -Co.001 -Co.001 
Two-way interaction 
F 
1.25 1.08 0.57 2.27 0.06 2.45 
z-o.2 >0.2 >0.4 >O.l >0.8 z-o.1 
‘Arithmetic meanfstandard deviation (numbers of measurements made are given in parentheses). 
bGeometric mean [antilog standard deviation in square brackets] (numbers of measurements made are given in parentheses). 
‘F=variance ratio statistic; P=probability. 
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that the sickle-cell genotype modified the effect of iron 
supplementation on any of these variables by 36 weeks 
gestation. However, the observed effect of iron on both 
PCV and Hb was much greater in AA than in AS women. 
Mean PCV and Hb measured shortly after delivery by 
genotype and treatment groups are shown in Table 3. 
Both Hb and PCV were lower among those with the AS 
genotype and iron supplementation was associated with 
statistically significant increases in Hb and PCV. How- 
ever, the overall increases in these quantities were en- 
tirely accounted for by the individuals with AA geno- 
type. Women with the AS genotype who received the 
supplements had slightly lower Hb and PCV than those 
who received placebo. The analysis of covariance indi- 
cated that there were highly significant interactions be- 
tween the effects of iron supplementation and haemo- 
globin genotype on both Hb and PCV (Table 3). 
Effects of iron supplementation on birth weight 
Among women with the haemoglobin genotype AA, 
the mean birth weight of babies born to iron-sup- 
plemented women was higher than that of babies born to 
women who received placebo (Table 3). In contrast, 
among women with the haemoglobin genotype AS the 
mean birth weight of babies born to women who received 
iron supplementation was less than that of the babies of 
women who received placebo. The analysis of covari- 
ante, which allowed for confounding effects of maternal 
height, indicated that the effect of supplementation was 
significantly modified by the genotype. 
Discussion 
Most studies have shown that pregnant women with 
the haemoglobin genotype AS have normal fertility and 
normal abortion, prematurity and still birth rates in both 
Table 3. Effect of iron supplementation on bii weight and haematological and biochemical values adjusted for 
haemoglobii genotype and baseline values shortly after delivery 
Genotype treatment 
Packed cell 
volume (%)” 
Birth weight 
(g)” 
AA Iron 
2 
Placebo 
Iron 
AS Placebo 
Analysis of covarianceb 
Main effects 
Genotype 
; 
32.4+4.9 (183) 10.8k1.9 (148) 3.113+400 (182) 
30.254.7 (167) 9.8f1.7 (142) 3.026+384 (164) 
28.6556 (39) 9.5k2.0 (33) 3.010+425 (41) 
30.853.8 (40) lO.lk1.8 (34) 3.109+402 (43) 
6.48 4.33 0.02 
0.01 -co.05 0.9 
Iron 
F 13.56 0.32 
P <O.Ol <O.OOl 
Two-way interaction 
F 10.91 8.76 
P CO.01 CO.01 
aMeans+standard deviations (numbers of women studied are given in parentheses). 
bF=variance ratio statistic; P=probability. 
0.6 
4.54 
<0.03 
Table 4. Peripheral blood and placental malaria infection in pregnant women with haemoglobin genotype AA or AS 
according to whether they received iron supplementation or placebo during pregnancy 
Genotype Treatment 
2; 
Iron 
Placebo 
AS Iron 
AS Placebo 
Logistic regressiona 
Main effects 
Gepotype 
Xl 
P 
Iron 
X2, 
P 
Two-wav interaction 
Peripheral blood parasitaemia 
36 weeks Post-natal 
501201 (25%) 331197 (17%) 
53/198 (27%) 231183 (13%) 
16146 (35%) 8144 (18%) 
13151 (25%) 9/45 (20%) 
0.6 1.1 
0.4 0.3 
0.0 0.9 
1.0 0.3 
Placental 
malaria 
831158 (53%) 
911154 (59%) 
22129 (76%) 
19133 (58%) 
2.3 
0.1 
0.2 
0.7 
1.2 0.5 3.5 
0.3 0.5 0.06 
Effects of iron supplementation on malaria 
The prevalence of malaria parasites in peripheral blood 
was very similar in all 4 groups (Table 4). Parasite den- 
sities were also similar (results not shown). Placental ma- 
laria was most frequent in the iron-supplemented AS 
women, and the interaction term in the logistic re- 
gression analysis, which tested whether the effects of 
supplementation were different in the 2 genotypes, was 
of borderline significance. 
malaria endemic and non-endemic areas (ADAMS et al., 
1953; WHALLEY et al., 1963; FLEMING et al., 1979). Opin- 
ion is divided as to whether women with the genotype AS 
are at increased risk of anaemia during pregnancy 
(MCCURDY, 1964; FLEMING et al., 1968; BLANK & 
FREEDMAN, 1969; VAN DONGHEN et al., 1982). In our 
study, the AS women had lower Hb and PCV irrespec- 
tive of iron supplementation. 
This increase in anaemia might reflect the different re- 
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sponse to malaria infection of the AS genotype. Many 
studies have shown that possession of the AS genotype 
protects African children from clinical malaria, particu- 
larly from severe forms (ALLISON, 1957). The advantage 
of the AS genotype is less marked in individuals with 
high levels of immunity and parasite rates and densities 
are usually similar in endemic areas in adults with either 
the AA or AS genotype (FLEMING et al., 1979). The in-- 
fluence of haemoglobin genotype on malaria during preg- 
nancy in semi-immune women is not clearcut. BRABIN & 
PERRIN (1985) did not find anv difference in oarasite 
rates between. AA and AS pregnant women in *Kenya. 
However. in Nigeria. FLEMING & HARRISON (1984) 
found that in pri&gravidae, whose immunity to &alar& 
was suppressed, parasite densities were lower in women 
in the ginotype AS than in those with the genotype AA. 
AS women also had lower malaria antibodv levels than 
those with the genotype AA (CORNILLE-BRAGGER et al., 
1979), perhaps because they were exposed to less 
antigenic stimulation. Our study demonstrated no overall 
effect of haemoglobin genotype on peripheral parasitae- 
mia; however, the malariological surveillance was not in- 
tense and we studied only multigravid pregnant women 
who are less imrnunosuppressed than primigravidae. 
Pregnant women with the AS haemoglobin genotype 
showed a poor haematolo ical 
plementation which was ‘i 
response to iron sup- 
a so associated with reduced 
birth weight of their children. The most likely explana- 
tion is that iron supplementation i creased the suscepti- 
bility of these women to malaria. Two previous studies 
have shown that parenteral iron administration during 
pregnancy can in&ease the prevalence of malaria infec- 
tion (BYLES & D’SA. 1970: OPPENHEIMER et al.. 19861. 
Our hata suggested, ilbeit inconclusively, that tiere was 
increased placental malaria in the supplemented AS 
roup, 
it 
and hence that such effects can depend on the 
aemoglobin genotype. It may be that pregnant women 
with AS genotype rely less on the immune response 
against malaria than do AA women, but achieve a similar 
level of protection as a result of additional genotype-spe- 
cific non-immunological mechanisms. If iron supplemen- 
tation were to interfere with these AS specific mechan- 
isms, then AS women receiving iron would have an 
enhanced risk of malaria. 
A less likely explanation for the adverse effects in AS 
women is that administration of iron increased haemo- 
lysis of AS red blood cells by promoting auto-oxidation 
of haemoglobin S (but not of haemoglobin A), generation 
of free oxygen radicals which damage the red cell mem- 
brane, and further damage it by the deposition of fer- 
ritin-like and haemosiderin-like iron on the red cell sur- 
face (RICE-EVANS & BAYSAL, 1987; HEBBEL, 1990). 
Finally, it is possible that, independently of the effects of 
malaria, AS subjects do not utilize iron as well as subjects 
with the AA genotype, but we are unaware of any evi- 
dence for this. 
This study provided evidence of an interaction be- 
tween a micronutrient and a genotype in affecting sus- 
ceptibility to a parasitic disease. The results suggest hat 
pregnant women resident in malaria endemic areas who 
are known to have the haemoglobin genotype AS should 
not routinely be given iron supplementation during preg- 
nancy. Further, larger studies are needed to confirm our 
findings and to determine the balance of advantages and 
disadvanta 
f 
es of such supplements. However, if iron is 
given to A women, it should be accompanied by admin- 
istration of effective malaria chemoprophylaxis regardless 
of maternal parity. Further studies are required to deter- 
mine whether iron supplementation i  pregnancy is also 
ineffective among pregnant women with the AS genotype 
resident in areas where malaria is not endemic. 
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